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Abstract
To investigate the histological and immunohistochemical effects of aqueous leaf extract of Xylo-
pia aethiopica on the pancreas in streptozotocin-induced diabetic rats, 30 adult Wistar rats were 
divided into three groups (n=10). Group A was the control (administered with equivalent vol-
ume of citrate buffer), group B animals were made diabetic by a single intraperitoneal injection 
of streptozotocin dissolved in citrate buffer (65 mg/kg), group C animals were made diabetic 
as above and treated with 200mg/kg body weight of aqueous leave extract of Xylopia aethiop-
ica for 25 days. Upon animal sacrifice, the pancreas were excised, fixed in 10% formol saline 
and processed for light microscopy and immunohistochemistry.. The results revealed destruc-
tion of the islet cells in the untreated diabetic group as compared with the controls. The extract 
treated group was characterized by recovery/regenerative processes indicated by improvement 
in islet morphology. In untreated diabetic rats immunoreactive β-cells were sparse, at variance 
from the controls. The group treated with aqueous leaf extract of Xylopia aethiopica revealed 
more intense staining for insulin and significant (p<0.05) increase in the percentage of immuno-
labelled surface area when compared with the untreated diabetic group, suggesting the ability 
of β-cells to secrete insulin in the extract treated rats. We conclude that the aqueous leaf extract 
of Xylopia aethiopica improves recovery process of β-cells in streptozotocin-induced diabetic rats 
and might become useful in the management of diabetes related complications.
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Introduction
Diabetic mellitus is a chronic disease characterized by relative or absolute deficien-
cy of insulin, resulting in glucose intolerance. It develops in 4-5 million persons in the 
United States (approximately 2% of the population) (Wolosin and Edelman, 2000; Piya-
chaturawat et al., 1991). The classic symptoms of diabetes mellitus result from abnor-
mal glucose metabolism (Wolosin and Edelman, 2000). Deficiency of insulin results in 
failure of glucose transfer from the plasma into the cells. This situation is also called 
“starvation in the midst of plenty”. The body responds as if it was in the fasting state, 
with stimulation of glucogenolysis, gluconeogenesis and lipolysis producing ketone 
bodies (Bastaki et al., 2010). Pancreatic exocrine dysfunction occurs in up to 80% of 
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individuals with type 1 diabetes but is rarely significant enough to lead to any clini-
cal problems with digestion (Wolosin and Edelman, 2000). The pancreas has a tremen-
dous reserve, and a modest reduction in pancreatic enzyme secretion rarely leads to 
difficulty in digesting or absorbing carbohydrate, fat, or protein. In many animal spe-
cies, streptozotocin (STZ) induces diabetes that resembles human hyperglycemic non 
ketotic diabetes mellitus (Weir et al., 1981). This effect has been extensively studied and 
appears to be mediated through a lowering of β cell nicotinamide adenine dinucleo-
tide (NAD+) and results in histopathologic alteration of pancreatic islet beta cells (Karu-
nanayake et al., 1974). In immune-mediated diabetes, the rate of β-cell destruction is 
quite variable, being rapid in some individuals (mainly infants and children) and slow 
in others (mainly adults) (Zimmet et al., 1994). Some patients, particularly children and 
adolescents, may present with ketoacidosis as the first manifestation of the disease. 
Others have modest fasting hyperglycemia that can rapidly change to severe hypergly-
cemia and/or ketoacidosis in the presence of infection or other stress. Still others, par-
ticularly adults, may retain residual β-cell function sufficient to prevent ketoacidosis for 
many years; such individuals eventually become dependent on insulin for survival and 
are at risk for ketoacidosis. At this latter stage of the disease, there is little or no insulin 
secretion, as manifested by low or undetectable levels of plasma C-peptide. Immune-
mediated diabetes commonly occurs in childhood and adolescence, but it can occur at 
any age, even in the 8th and 9th decades of life (Gavin et al., 2003).
Herbs such as Xylopia aethiopica (X. aethiopica) posses hypoglycemic and antihy-
perlipidemic effects in adult Wistar rats (Blanche et al., 2013). Recently, Gometi et al., 
(2014) reported a significant decrease in the liver function test following treatment of 
diabetic rats with extract of X. aethiopica. Virtually every part of X. aethiopica has medici-
nal value. It will be interesting to note that ailments such as candidiasis, fever, cough, 
dyspepsia and skin infections can be treated using X. aethiopica (Fleischer et al., 2008). 
Several reports have demonstrated the antimicrobial potential of X. aethiopica (Boakye-
Yiadom et al., 1977; Thomas, 1989; Tatsadjieu et al., 2003; Asekun and Adeniyi, 2004; 
Okigbo et al., 2005). Despite reports on the antihyperglycemic effect of X. aethiopica 
(Ogbonnia et al., 2008; Baldé et al., 2006), the morphological transformation within the 
pancreas leading to the hypoglycemic state is yet to be thoroughly investigated. The 
adoption of complementary medicine in modern era has increased tremendously. This 
is because some of the synthetic drugs being used today eventually have some adverse 
effects on the patients. In view of the up surge in the use of herbal therapy, it becomes 
therefore very important to under study its effects on pancreatic morphology.
The aim of this study was to investigate the effect of aqueous leaf extract of X. 
aethiopica on the pancreas in STZ-induced diabetic rats using histological and immu-




Thirty male albino rats of the Wistar strain were maintained under standard lab-
oratory conditions of light, humidity and temperature. The animals were acclima-
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tized for two weeks before the commencement of the research work. Animals were 
fed with standard rat diet and given water liberally. All the animal experiments were 
conducted in accordance with the “Guide for the Care and Use of Laboratory Ani-
mals” prepared by the Institute of Public Health, Obafemi Awolowo University (Eth-
ics No: IPHOAU/12/61).
Induction of experimental diabetes
Streptozotocin (65 mg/kg body weight) dissolved in 0.1 mol/L sodium citrate 
buffer (pH 6.3) was injected intraperitoneally to animals in groups B and C while ani-
mals in group A  received an equivalent volume of 0.1 mol/L sodium citrate buffer 
(pH 6.3). Before the commencement of the experiments, all the animals were fasted 
for 16 h, but still allowed free access to water. At the end of the 16 h fasting period – 
taken as 0 h – blood glucose levels (initial glycemia) were determined and recorded. 
Three days after hyperglycemic status had been confirmed, the leaf extract of X. aethi-
opica in aqueous solution was administered orally through gavages at a concentration 
of 200 mg/kg body weight/rat/day. 
Determination of blood glucose level
Blood glucose level was done using a digital glucometer (Accu-chek® Advantage, 
Roche Diagnostic, Germany) consisting of a digital meter and the test strips. Blood 
sample was obtained from the tail vein to determine the hyperglycemic state on 3rd 
day. This was again determined on the 14th and 28th day.
Experimental design
The animals were divided into three groups as follows, with ten animals in each 
group:
Group A: Control rats were administered intraperitoneally with an equivalent vol-
ume of 0.1mol/L sodium citrate buffer.
Group B: Rats made diabetic through intraperitoneal STZ (65 mg/kg body 
weight) dissolved in 0.1 mol/L sodium citrate buffer (pH 6.3).
Group C: Rats made diabetic with STZ, as above, and then treated orally with 
aqueous leaf extract of X. aethiopica (200 mg/kg body weight/day/rat) in aque-
ous solution for 25 days after hyperglycemia was confirmed, which happened on 
the third day from streptozotovcin injection which was taken as day 0 of the extract 
administration.  The leaves of X. aethiopica were procured from a local market in Ile-
Ife, Nigeria.
Animal sacrifice
All the animals were treated humanely and sacrificed under chloroform anesthe-
sia twenty four hours after the last administration. Blood samples were collected by 
cardiac puncture. The animals were opened up and the pancreas was excised and 
fixed for light microscopy.
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Biochemical assays
Serum was obtained after centrifuging the blood samples for 5 min at 5000 rpm 
in a Benchtop Refrigerated centrifuge (Centurion Scientific centrifuge, R8000 series, 
UK). The serum obtained was used for the determination of triglyceride (Footsati and 
Prencipe, 1982), total cholesterol (Allain et al., 1974) and high-density lipoprotein-cho-
lesterol (Allain et al., 1974) using respective diagnostic commercial kits from Randox, 
Northern Ireland. Very low-density lipoprotein cholesterol and low-density lipopro-
tein cholesterol were calculated adopting Friedewald’s equation (Friedewald et al., 
1972).
Histology
The tissue was excised and fixed in 10% formol-saline and processed for light 
microscopic study. The processing was done using automatic tissue processor (ASP 
200S, Leica, Wetzlar, Germany). This included dehydration of the samples through 
graded ethanol, clearing in isopropanol and infiltration with paraffin wax at 56oC. 
The samples were immediately embedded in paraffin wax using Leica EG1150 H. 
A rotary microtome (Leica RM 2135) was used to obtain serial sections 5 µm thick 
which were stained with hematoxylin and eosin.
Immunohistochemistry 
Sections of the pancreas were immunostained for insulin. Slides were de-waxed, 
rehydrated, rinsed in 1% PBS (10 mmol/L Na2HPO4, 1.8 mmol/L KH2PO4, 137 
mmol/L NaCl and 2.7 mmol/L KCl; pH 7.4), and immersed in antigen retrieval 
solution (1:50 Low pH Dako-Envision; Dako, Glostrup, Denmark) and subjected 
to heat-induce antigen retrieval for 10 min in a microwave (LG, Englewood Cliffs, 
New Jersey; 1200W at medium-High level). The slides were rinsed in 1% PBS + 
Tween 20 and 1% PBS for 3 min. each. The sections were treated to block endog-
enous peroxidase by 3% H2O2 for 5 min, rinsed in 1% PBS + Tween 20, incubated 
with Sniper (Biocare Medical, Concord, California; it is used for blocking nonspe-
cific  background  staining  commonly found  with  immunohistochemistry) for 30 
min and rinsed again in 1% PBS + Tween 20 and 1% PBS for 5 min each rinse. Sec-
tions were later incubated for 2 h at room temperature with polyclonal guinea pig 
anti-insulin primary antibody (Ready-to-use, Dako Autostainer/Autostainer Plus). 
After rinsing in 1% PBS + Tween 20 and 1% PBS, 3 drops of Horseradish peroxi-
dase (Dako REAL EnVision-HRP, Rabbit/Mouse) were added to the slides, and then 
washed in 1% PBS + Tween 20 and 1% PBS for 5 min each. Three drops of substrate 
chromogen (Dako DAB Chromogen,) solution was added to the slides for 3 min. 
Thereafter, the slides were washed with distilled water and counter stained with 
Mayer’s hematoxylin, dehydrated, cleared in xylene and mounted with DPX (Bela-
mi fine chemicals, Maharashtra, India). The antibody labeled the cytoplasm of insu-
lin producing beta-cells in the pancreas deep brown. The sections were examined 
and photographed using a Zeiss (Oberkochen, Germany) Axioscope A1 microscope 
with digital camera attached. 
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Quantitative analysis of immuno-labeled surface area
Five areas of the pancreas per specimen were randomly selected and photo-
graphed at magnification x400. The intensity of labeling with anti-insulin antibody 
was evaluated with Zeiss AxioVision Image analysis software package version 4.8.3. 
The size of the measurement frame was expressed as µm2. This measurement cor-
responded to a mean area frame of 23485.01µm2. Intensity of immunoreactivity was 
expressed as percent labeled surface area / frame surface area.
Statistical analysis
Statistical analysis was carried out using statistical package SPSS version 17.0 
(SPSS, Cary, NC, USA) with Duncan’s Multiple Range Test option. One-way analy-
sis of variance was used to evaluate statistical significance of the differences between 
animal groups. A value of p≤0.05 was considered significant. Data are reported as 
mean ± standard deviation (SD).
Results
Body weight
There was a decline in the average body weight of the diabetic rats after 14 days 
of induction. On the contrary, the extract-treated group showed a gradual increase 
in weight from the period of commencement of the treatment until the 28th day 
(Table 1).
Blood glucose level
The average blood glucose level increased significantly 48 h after the administra-
tion of STZ. This increment was sustained in the untreated diabetic animals till the 
28th day. However, the blood glucose level was significantly (p<0.05) lowered in the 
extract-treated group when compared with the untreated diabetic group from the 
period of commencement of the treatment until the 28th day (Table 2).
Table 1 – Effects of Xylopia aethiopica on the body weight (g) of control rats (group A), rats made diabetic 
by streptozotocin (group B) and diabetic rats treated with X. aethiopica extract (group C). Mean ± standard 
deviation; N = 10 in each group.
0 day 14 days 28 days
GROUP A 165.80±16.31c 238.60±21.50b 241.00±20.73b
GROUP B 144.28±  7.60b 156.57±39.11a 143.14±54.97a
GROUP C 100.14±22.71a 182.85±21.51a 187.57±23.79a
In each column, values indicated with different letters (a, b, c) differ significantly from each other (p < 0.05) 
while values indicated with the same letter do not differ significantly from each other.
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Table 2 – Effects of Xylopia aethiopica on the blood glucose level (mg/dl) of control rats (group A), of rats 
made diabetic by streptozotocin (group B) and diabetic rats treated with X. aethiopica extract (group C). 
Mean ± standard deviation; N = 10 in each group.
0 day 3 days 14 days 28 days
GROUP A 111.40±7.23b 111.00±  5.38a 102.60±  19.80a 112.60±    5.02a
GROUP B   86.71±9.12a 283.28±29.70b 353.71±102.13b 361.85±110.97b
GROUP C 113.57±4.23b 316.28±37.78b 120.57±    3.99a 107.16±  22.68a
In each column, values indicated with different letters (a, b) differ significantly from each other (p < 0.05) 
while values indicated with the same letter do not differ significantly from each other.
Table 3 – Effects of Xylopia aethiopica on the blood lipid levels (mmol/L) of control rats (group A), of rats 
made diabetic by streptozotocin (group B) and diabetic rats treated with X. aethiopica extract (group C). 
Mean ± standard deviation; N = 10 in each group.





GROUP A 0.62±0.26a 0.55±0.29a 1.48±0.22a 0.37±0.28a 0.24±0.13a
GROUP B 1.70±0.63b 0.80±0.44a 1.32±0.49a 1.33±0.57b 0.36±0.20a
GROUP C 1.57±0.46b 0.61±0.55a 1.16±0.75a 1.30±0.33b 0.27±0.25a
P<0.06 P<0.605 P<0.632 P<0.004 P<0.601
TC = total cholesterol; TG = triglycerides; HDL-C = high density lipoprotein cholesterol; LDL-C = low density 
lipoprotein cholesterol; VLDL-C = very low density lipoprotein cholesterol. In each column, values indicated 
with different letters (a, b) differ significantly from each other (p < 0.05) while values indicated with the same 
letter do not differ significantly from each other.
Lipid profile
The result showed that total cholesterol, triglyceride, low density lipoprotein 
cholesterol and very low density lipoprotein cholesterol were increased when the 
untreated diabetic group was compared with the extract treated animals. The high 
density lipoprotein cholesterol was not significantly different in all the groups as 
shown in Table 3.
Histopathology
The results revealed multiple vascular congestion and destruction of islets cells in 
the untreated diabetic group as compared with the control group. The microanatomy 
of the islet in the extract-treated group was characterized by recovery/regenerative 
processes as evident by the reduction in vascular congestion and improvement in 
islet morphology (Fig. 1). 
Immunohistochemistry
The immunohistochemical staining of the pancreas of the diabetic group showed 
that immunoreactive β-cells were sparse compared with the control group. The group 
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treated with aqueous leaf extract of X. aethiopica revealed better staining pattern for 
insulin than the diabetic group (Fig 2). The results of image analysis are shown in 
Table 4. The mean percentages (± SD) of the relative surface area stained for insulin 
Figure 1 – Photomicrograph of the pancreas in: (a) a control rat, note the islet (IL); (b) a rat induced to 
become diabetic with streptozotocin, note the disruption of islets (IL), multiple congested blood vessels 
(arrow) and lumen of an exocrine duct (S); (c) a diabetic rat treated with aqueous leaf extract of X. aethiopi-
ca, note the better islet morphology (IL) and reduced congestion of blood vessels (arrow) as compared with 
panel (b). Hematoxylin and eosin, X400.
Figure 2 – Photomicrograph of the pancreas showing insulin immunoreactivity of β cells (dark brown) in: (a) 
a control rat, note the intense immunoreactivity; (b) a rat induced to become diabetic with streptozotocin, 
note the reduced immunoreactivity; (c) a diabetic rat treated with aqueous leaf extract of X. aethiopica, note 
the improvement in immunoreactivity as compared with panel (b). Indirect immunohistochemistry for insu-
lin, X400.
Table 4 – Morphometric analysis of insulin immuno-labeling of control rats (group A), of rats made diabetic 
by streptozotocin (group B) and diabetic rats treated with X. aethiopica extract (group C). Mean ± standard 
deviation; N = 10 in each group.
GROUP A GROUP B GROUP C
Field surface area (µm2) 23485.01 23485.01 23485.01
Immuno labeled surface area (%) 5.31±5.35b 0.45±1.01a 4.72±2.08b
In each row, values indicated with different letters (a, b) differ significantly from each other (p < 0.05) while 
values indicated with the same letters do not differ significantly from each other.
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were 5.31±5.35, 0.45±1.01, 4.72±2.08 for control, diabetic and extract-treated diabetic 
groups respectively (N = 10 for each group). There was a significant effect of X. aethi-
opica on the expression of insulin when compared with the diabetic group.
Discussion
Diabetes occurs when there is insufficient production of insulin or when the avail-
able insulin is not effectively utilized (Awasthi et al., 2014). Estimate suggests that 
about 346 million people worldwide have diabetes. About 1.5 million people die on 
a yearly basis as a result of hyperglycemia (WHO, 2015). Low- and middle-income 
countries are majorly affected by this death. WHO projects that diabetes death will 
double between 2005 and 2030. 
The present study shows a gradual decline in the average body weight of the 
untreated diabetic group. The reason may be connected with the release of free radi-
cals or glucose intolerance which occurs in ill health conditions like diabetes. Several 
authors have associated diabetes to the release of free radicals (Keaney and Loscalzo 
1999; Haffner 2000; Bonnefont-Rousselot et al., 2000). X. aethiopica has been known for 
its highly rich antioxidant content (Blanche et al., 2013) which may have neutralized 
the free radical so generated thus leading to the observed increment in the average 
body weight in the extract treated diabetic animals.
The result also showed that there was a gradual drop in the blood glucose level 
from the day the extract treatment started (3rd day) till the end of the study (28th day) 
unlike the consistent increment noticed in the untreated diabetic animals. This obser-
vation may be due to the hypoglycemic properties of X. aethiopica (Ogbonnia et al., 
2008, 2010). Plants with hypoglycemic properties have the tendency to reduce blood 
glucose level.
Several plasma lipids were increased in the diabetic group when compared with the 
extract-treated animals, except high density lipoprotein cholesterol which was not sig-
nificantly different among groups. Triglycerides have been reported to increase in the 
diabetic state (Suryawanshi et al., 2006). There seem to be a correlation between the 
level of insulin and bioavailability of triglyceride. For instance, Shih et al., 1997 pro-
posed the increase in triglyceride to be due to insulin insufficiency. Insulin insufficiency 
leads to derangement in glucose utilization, hyperglycemia and release of fatty acids 
from adipose tissue for energy production. The excess of these fatty acids which are 
eventually accumulated in the liver are then converted to triglyceride. The leaf extract 
of X. aethiopica was able to normalize the triglyceride level as compared with the con-
trol group. The total cholesterol increment in the diabetic animals in this study may be 
due to inhibition in cholesterol catabolism as proposed by Suryawanshi et al., (2006). 
Treatment of diabetic animals with X. aethiopica improved total cholesterol levels. 
Receptors of low density lipoprotein cholesterol decrease with decrease in insulin lev-
el (Suryawanshi et al., 2006). In the extract-treated group there was a reduction in low 
density lipoprotein cholesterol when compared with the diabetic group. The reason for 
this may be due to the antioxidant and antihyperlipidemic properties of X. aethiopica. 
This may have improved the insulin levels thus increasing the low density lipoprotin 
cholesterol receptors leading to decrement in the serum levels of the corresponding 
particles, as shown by previous studies (Suryawanshi et al., 2006; Satheesh and Pari, 
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2008; Al-Jamal and Alqadi, 2011). The non significant difference noticed in high density 
lipoprotein cholesterol was not new as Cohen et al., (1979) also reported the same in a 
similar study. It is therefore presumed that the antihyperlipidemic ability of X. aethiopi-
ca may be due to its hypolipidemic activity as shown by Nwozo et al.,(2011) and Nwai-
chi and Igbinobaro (2012). This however might serve as a means of protection against 
the development of atherosclerosis and other cardiovascular diseases.  
There was a disruption of islet morphology, vascular congestion as well as decline 
in immunoreactive β-cells in the diabetic group, which was significant upon image 
analysis. These findings indicate dysfunction of the insulin secreting β-cells. The X. 
aethiopica treated group revealed better morphology and significant increase in insu-
lin expression when compared with the diabetic group. This indicates ability of the 
aqueous extract of X. aethiopica to stimulate islets of Langerhans to secrete reasona-
ble level of immunoreactive insulin. This was accomplished by gradual reduction in 
vascular congestion and regeneration of the immunoreactive β-cells within the islets. 
Similar study on β-cells had also shown that plant extracts are capable of stimulating 
regeneration of β-cells (Lukiati et al., 2012).
We therefore conclude that aqueous leaf extract of X. aethiopica improves the mor-
phology of islets and stimulates the recovery of β-cells in STZ-induced diabetic rats 
and, by extension, might be of use in the management of diabetes and related com-
plications.
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